Related Experiment Video

Updated: Jun 19, 2026

Optimization of a Multiplex RNA-based Expression Assay Using Breast Cancer Archival Material
11:12

Optimization of a Multiplex RNA-based Expression Assay Using Breast Cancer Archival Material

Published on: August 1, 2018

Increased HER2/neu expression in recurrent hormone receptor-positive breast cancer

Virginia G Kaklamani, Mary Cianfrocca, Jennifer Ciccone

    Biomarkers : Biochemical Indicators of Exposure, Response, and Susceptibility to Chemicals
    |October 21, 2009
    PubMed
    Abstract

    No abstract available in PubMed .

    More Related Videos

    Building Up a High-throughput Screening Platform to Assess the Heterogeneity of HER2 Gene Amplification in Breast Cancers
    11:34

    Building Up a High-throughput Screening Platform to Assess the Heterogeneity of HER2 Gene Amplification in Breast Cancers

    Published on: December 5, 2017

    Related Experiment Videos

    Last Updated: Jun 19, 2026

    Optimization of a Multiplex RNA-based Expression Assay Using Breast Cancer Archival Material
    11:12

    Optimization of a Multiplex RNA-based Expression Assay Using Breast Cancer Archival Material

    Published on: August 1, 2018

    Building Up a High-throughput Screening Platform to Assess the Heterogeneity of HER2 Gene Amplification in Breast Cancers
    11:34

    Building Up a High-throughput Screening Platform to Assess the Heterogeneity of HER2 Gene Amplification in Breast Cancers

    Published on: December 5, 2017

    Related Concept Videos

    Mitogens and the Cell Cycle02:38

    Mitogens and the Cell Cycle

    Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
    Targeted Cancer Therapies02:57

    Targeted Cancer Therapies

    The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
    There are several types of targeted therapies against specific...

    Articles linked to this work by shared authors, journal, and citation graph.

    Personal pathways to success: an innovative program to overcome cancer patient barriers to tobacco cessation and promote patient participation.

    Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer·2026

    Person-centered intervention response in primary progressive aphasia: A secondary analysis of the Communication Bridge-2 randomized clinical trial.

    Alzheimer's & dementia (New York, N. Y.)·2026

    Identifying premenopausal patients with early-stage hormone receptor-positive breast cancer at minimal risk of distant recurrence by breast cancer index.

    Breast (Edinburgh, Scotland)·2026

    Contributions of selenoproteins to breast cancer etiology and racial disparity.

    Cancer causes & control : CCC·2026

    Dementia Care Research and Psychosocial Factors.

    Alzheimer's & dementia : the journal of the Alzheimer's Association·2025

    Dementia Care Research and Psychosocial Factors.

    Alzheimer's & dementia : the journal of the Alzheimer's Association·2025

    Effect of colchicine on C-reactive protein level following hospitalization for myocardial infarction: a meta-analysis of randomized, placebo-controlled trials.

    Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals·2026

    Association between the Geriatric Nutritional Risk Index and the Risk of Readmission in Older Inpatients: A Systematic Review and Meta-Analysis.

    Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals·2026

    Combined metabolic-inflammatory biomarkers for predicting complicated acute appendicitis: a comparative analysis.

    Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals·2026

    Integrated molecular, epigenetic, microbial and liquid biopsy biomarkers in colorectal cancer: implications for prognosis and precision therapy.

    Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals·2026

    Diagnostic value of serum neuron-specific enolase and S100 calcium-binding protein B for sepsis-associated encephalopathy: a systematic review and meta-analysis.

    Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals·2026

    Time-Dependent Changes in YKL-40 and Inflammatory Markers in Experimental Acute Mesenteric Ischemia.

    Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals·2026
    See all related articles
    JoVE
    x logofacebook logolinkedin logoyoutube logo
    ABOUT JoVE
    OverviewLeadershipBlogJoVE Help Center
    AUTHORS
    Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
    LIBRARIANS
    TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
    RESEARCH
    JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
    EDUCATION
    JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
    Terms & Conditions of Use
    Privacy Policy
    Policies
    Jove
    Visualize
    Contact Us